• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antibodies to be used as a last resort

kiwibird

Editor, Senior Moderator
Antibodies flagged for 'last-resort' treatment
SWINE FLU OUTBREAK
Ella Lee
Jul 18, 2009

Antibodies carried by recovered swine flu patients will be used to develop a "last resort" weapon against the virus that is causing life-threatening infections in Hong Kong.

The Food and Health Bureau is working with the University of Hong Kong to use antibodies collected from patients to make a drug for those who fail to respond to Tamiflu and Relenza. This emerged as it was announced that a 39-year-old woman in critical condition at the Caritas Medical Centre had become the seventh severe case. The woman, who had been treated for flu symptoms and discharged before being readmitted five days ago, was confirmed to have swine flu yesterday.

A 37-year-old Filipino domestic helper at United Christian Hospital and a 48-year-old woman at Queen Elizabeth Hospital remain in critical condition while three others are serious. A man with a formerly severe infection is in a stable condition.

A man with a superbug who died last week was found to have swine flu but it has not been confirmed as the cause of death.

The number of swine flu cases in Hong Kong reached 1,640 yesterday, with 88 newly reported cases.

The Caritas patient developed flu symptoms last Thursday and went to the accident and emergency department on Sunday. She was diagnosed with an upper respiratory tract infection, treated and discharged.

When she failed to recover, she sought consultation at the same department again on Monday. The hospital admitted her and diagnosed her with a chest infection. She tested negative for swine flu on Tuesday. Her condition deteriorated yesterday and she needed breathing assistance.

Medical sources, meanwhile, said recovered patients would be asked to donate blood to the Red Cross transfusion service so the antibodies could be extracted. The US Centres for Disease Control and Prevention is working on the same project.

University microbiologist Ho Pak-leung said antibodies in blood serum could be collected through a special process and made into a drug.

"The serum therapy will not be the first choice for treating swine flu, because there are no clinical trials to prove its effectiveness. It can only be used when patients do not respond to antivirals such as Tamiflu and Relenza," he said.

Professor Ho advised doctors to prescribe Tamiflu to patients with flu symptoms without waiting for laboratory confirmation. He said Tamiflu should be prescribed if patients had high risk factors, such as old age and chronic illness and pregnancy, and if they suffered from pneumonia requiring hospital care.

Among the seven patients who developed complications, the average time between symptom onset and admission was three to 10 days.

Tamiflu works best if the drug is given to patients within 48 hours of the development of flu symptoms. In some cases, patients are not given Tamiflu immediately after being admitted to hospital, meaning they miss the so-called "golden period" for Tamiflu therapy.

New cases reported yesterday included a nurse at Queen Mary Hospital and six people from SAHK Erik Kvan Workshop in Shau Kei Wan, a residential centre for the physically and mentally disabled.
http://www.scmp.com/portal/site/SCM...0VgnVCM100000360a0a0aRCRD&ss=Hong+Kong&s=News
 
Re: Antibodies to be used as a last resort

Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?

[SIZE=-1] <nobr>Thomas C. Luke, MD, MTMH</nobr>; <nobr>Edward M. Kilbane, MD, MPH</nobr>; <nobr>Jeffrey L. Jackson, MD, MPH</nobr>; and <nobr>Stephen L. Hoffman, MD, DTMH</nobr> [/SIZE]

[FONT=arial, verdana, helvetica, sans-serif][SIZE=-1]17 October 2006 | Volume 145 Issue 8[/SIZE][/FONT]

[SIZE=-1]Background: Studies from the Spanish influenza era reported<sup> </sup>that transfusion of influenza-convalescent human blood products<sup> </sup>reduced mortality in patients with influenza complicated by<sup> </sup>pneumonia. Treatments for H5N1 influenza are unsatisfactory,<sup> </sup>and convalescent human plasma containing H5N1 antibodies could<sup> </sup>be an effective therapy during outbreaks and pandemics.<sup> </sup>
Purpose: To see whether transfusion with influenza-convalescent<sup> </sup>human blood products reduced the risk for death in patients<sup> </sup>with Spanish influenza pneumonia.<sup> </sup>
Data Sources: Manual search of English-language journals from<sup> </sup>1918 to 1925. Citations from retrieved studies were also searched.<sup> </sup>
Study Selection: Published English-language studies that had<sup> </sup>at least 10 patients in the treatment group, used convalescent<sup> </sup>blood products to treat Spanish influenza pneumonia in a hospital<sup> </sup>setting, and reported on a control or comparison group.<sup> </sup>
Data Extraction: Two investigators independently extracted<sup> </sup>data on study characteristics, outcomes, adverse events, and<sup> </sup>quality.<sup> </sup>
Data Synthesis: Eight relevant studies involving 1703 patients<sup> </sup>were found. Treated patients, who were often selected because<sup> </sup>of more severe illness, were compared with untreated controls<sup> </sup>with influenza pneumonia in the same hospital or ward. The overall<sup> </sup>crude case-fatality rate was 16% (54 of 336) among treated patients<sup> </sup>and 37% (452 of 1219) among controls. The range of absolute<sup> </sup>risk differences in mortality between the treatment and control<sup> </sup>groups was 8% to 26% (pooled risk difference, 21% [95% CI, 15%<sup> </sup>to 27%]). The overall crude case-fatality rate was 19% (28 of<sup> </sup>148) among patients who received early treatment (after <4<sup> </sup>days of pneumonia complications) and 59% (49 of 83) among patients<sup> </sup>who received late treatment (after
ge.gif
4 days of pneumonia complications).<sup> </sup>The range of absolute risk differences in mortality between<sup> </sup>the early treatment group and the late treatment group was 26%<sup> </sup>to 50% (pooled risk difference, 41% [CI, 29% to 54%]). Adverse<sup> </sup>effects included chill reactions and possible exacerbations<sup> </sup>of symptoms in a few patients.<sup> </sup>
Limitations: Studies were few and had many methodologic limitations.<sup> </sup>No study was a blinded, randomized, or placebo-controlled trial.<sup> </sup>Some pertinent studies may have been missed.<sup> </sup>
Conclusions: Patients with Spanish influenza pneumonia who<sup> </sup>received influenza-convalescent human blood products may have<sup> </sup>experienced a clinically important reduction in the risk for<sup> </sup>death. Convalescent human H5N1 plasma could be an effective,<sup> </sup>timely, and widely available treatment that should be studied<sup> </sup>in clinical trials.[/SIZE]
Full Report available here:
http://www.h5n1experts.org/forum/showthread.php?t=594

Here at flutrackers we have had many discussions, including low tech ways to do this. There is even a plasma syringe available that separates the serum immediately.

The Hong Kong authorities must be seriously thinking that current anti-virals may not soon work!

"The serum therapy will not be the first choice for treating swine flu, because there are no clinical trials to prove its effectiveness. It can only be used when patients do not respond to antivirals such as Tamiflu and Relenza," he said.
[SIZE=-1]<sup> </sup> [/SIZE][FONT=arial, verdana, helvetica, sans-serif][SIZE=-1]

[/SIZE][/FONT]
 
Re: Antibodies to be used as a last resort

This has been discussed at FT in the past. "Sharpe" filled in the details.

.
 
Re: Antibodies to be used as a last resort

how much does it cost ?
do they pay recovered people for giving blood ?
are they traded,exported ?
how long are they good ?

is there a chart, how the price developed over time ?
 
Re: Antibodies to be used as a last resort

Can Antibodies be used in pregnant women where the immune system is working hard not to reject the fetus?
 
Re: Antibodies to be used as a last resort

AlaskaDenise - you are right! Did a quick google and there are many more syringes for this purpose on the market. I think we could only find one last time. They do say they are not for transfusion purposes - but I think there was a consensus that if there was a family member who had survived - it might not be a bad idea. If you are emotionally vulnerable and are told your loved one is not likely to survive unless... you are more likely to allow radical treatments.

GS - People can be motivated by a national pride and truly believe they are saving lives - I don't think they would charge for their blood. In a terrible pandemic they would be considered heroes.
 
Re: Antibodies to be used as a last resort

kiwi, that hero-motivation degrades quickly, when you have thousands of them...

if the blood is sold to nations who pay better - are they still heroes
when they save foreign lives (and collect money for their country
which may be used to save more lives)
 
Back
Top